PTC Therapeutics, Inc. (PTCT) Stock Forecasts

PTC Therapeutics, Inc. (PTCT) has received a "HOLD" investment rating from Argus, with a target price lowered to $79.00 from a current price of $73.31. The report highlights medium subratings for industry, financial strength, and value, while management, safety, and growth subratings are low. This assessment suggests a cautious outlook for the company's stock performance.